Nagi Bioscience is thrilled to announce the successful closure of its Series A funding round co-led by Swisscanto and imec.xpand.
SydLab™ One visits Ljubljana for EUROTOX 2023 to unlock the potential of micro-organisms for DART studie
Some thoughts of Nagi’s CSO Laurent Mouchiroud on NAMs in DART studies. Speaker at WC12 Niagara Falls.
C. elegans and the quest against cancer metastasis.
Nagi Bioscience showcased its new solution for C. elegans testing – SydLab™ One – at the recently concluded 24th International C. elegans Conference in Glasgow.
In a significant move towards ethical scientific practices, Canada has taken a decisive step to ban the testing of toxic chemicals on animals.
C. elegans worms have become the first living organism into which a 3D-printed conductive circuit has been successfully done
“This certification accredits that Nagi is fully ready to start scaling-up as commercial organization and to accomplish our mission of accelerating the transition to a new era of biological testing with our state-of-the-art technology.”
Nagi Bioscience has been selected for the prestigious SLAS Innovation AveNEW 2023 cohort.
We are pleased to announce that Nagi Bioscience is a sponsor of 2023 SSPT Annual Spring Meeting, where “Aging” is the highlighted topic.